Editorial: Real-World Evidence of Pediatric Exposure to Psychopharmacologic Medications

Julie M Zito; Susan DosReis; Bruce Carleton

doi:10.3389/fpsyt.2022.930276

Editorial: Real-World Evidence of Pediatric Exposure to Psychopharmacologic Medications

Front Psychiatry. 2022 Jun 10:13:930276. doi: 10.3389/fpsyt.2022.930276. eCollection 2022.

Authors

Julie M Zito^{1

2}, Susan DosReis^{1

2}, Bruce Carleton³

Affiliations

¹ Department of Pharmaceutical Health Services, University of Maryland, Baltimore, MD, United States.
² Department of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, United States.
³ Department of Pediatrics, Division of Translational Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.

No abstract available

Keywords: adolescents; children; pharmacoepidemiology; psychopharmacologic drugs; psychopharmacologic medications; real-world evidence (RWE); youth.

Publication types

Editorial